Multiple Sclerosis (MS) Drugs

| Avonex | Betaseron | Betaferon | Copaxone | Rebif |

 

Rebif (interferon beta-1a)

What is Rebif ?

Rebif is a drug used in the treatment of multiple sclerosis. It is from a class of drugs known as interferons.

Interferon beta-1a is a recombinant DNA produced synthetic of naturally occurring proteins.

Interferons are cytokines. Three major classes of interferon have been identified - interferon alpha, interferon beta and interferon gamma. Interferon alpha and beta form the Type I class of interferons and Interferon gamma is a Type II interferon.

Interferons are species specific. The effects and results of interferon therapy and animal experimentation is difficult to apply across the human-animal species barriers since the effects they have within any given species are different.

The specific interferon-induced proteins and mechanisms by which interferon beta-1a exerts its effects in multiple sclerosis (MS) have not been fully defined.

Rebif is administered by subcutaneous injection (injection under the skin) three times weekly.

 

 

 

 

 

Multiple Sclerosis

The incidence rate for non-identical twins, where one contracts Multiple Sclerosis, is approx 4%.

Early Symptoms

The nature of multiple sclerosis and the vagueness of a symptom appearing here or there over time, without any apparent connection means there is a lack of data on what can accurately be considered as early symptom of multiple sclerosis... Read More